Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine

Targeted immunotherapy of solid cancers with chimeric antigen receptor (CAR) T cells and immunocytokines are attractive options in that they both rely on the specificity of tumor-targeted antibodies. Since carcinoembryonic antigen (CEA) expression in both colon and breast cancers is correlated with...

Full description

Bibliographic Details
Main Authors:	Seung E. Cha, Maciej Kujawski, Paul J. Yazaki, Christine Brown, John E. Shively
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2021-01-01
Series:	OncoImmunology
Subjects:	carcinoembryonic antigen (cea) chimeric antigen receptor t cells (car t) immunocytokine lymphodepletion cea transgenic mice tumor immunity
Online Access:	http://dx.doi.org/10.1080/2162402X.2021.1899469

Similar Items

Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation
by: Maciej Kujawski, et al.
Published: (2020-01-01)

Association between Primary Perioperative CEA Ratio, Tumor Site, and Overall Survival in Patients with Colorectal Cancer
by: Thomas A. Odeny, et al.
Published: (2020-11-01)

Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer
by: Ernesto Lopez, et al.
Published: (2023-12-01)

The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review
by: Michael A. Turner, et al.
Published: (2021-12-01)

The Association of Carcinoembryonic Antigen (CEA) and Air Pollutants—A Population-Based Study
by: Yi-Jen Fang, et al.
Published: (2022-03-01)

Value of CEA level determination in gallbladder bile in the diagnosis of liver metastases secondary to colorectal adenocarcinoma
by: Rita Maria Aparecida Monteiro Moura, et al.
Published: (2001-05-01)

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
by: Christian Klein, et al.
Published: (2017-03-01)

CEA vaccines
by: Anchit Bhagat, et al.
Published: (2023-12-01)

Correlation Between Tumor Cell Differentiation and CEA Levels in Patients with Adenocarcinoma of the Rectum
by: Reno Rudiman, et al.
Published: (2020-12-01)

Clinical significance of the combination of preoperative SUVmax and CEA in patients with clinical stage IA lung adenocarcinoma
by: Asato Hashinokuchi, et al.
Published: (2022-09-01)

Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
by: Leilani Lakemeyer, et al.
Published: (2021-03-01)

Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells
by: Masayuki Shiozawa, et al.
Published: (2018-08-01)

CEA-Ki-67- Pathologic Subtype: An Adjunct Factor for Refining Prognosis in Stage I Pulmonary Adenocarcinoma
by: Dongzhi Yu, et al.
Published: (2022-04-01)

Association of preoperative and recurrent serum carcinoembryonic antigen and outcome of colorectal cancer patients with metastatic relapse
by: Shanyou Tong, et al.
Published: (2024-04-01)

Medullary Thyroid Carcinoma With Elevated Serum CEA and Normal Serum Calcitonin After Surgery: A Case Report and Literature Review
by: Li Chen, et al.
Published: (2020-10-01)

High Prevalence of Abnormal Carcinoembryonic Antigen in Diabetic Inpatients with Poor Glycemic Control
by: Liu XY, et al.
Published: (2022-08-01)

A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC)
by: Ioannis Passos, et al.
Published: (2021-06-01)

Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis
by: Awrad Nasralla, et al.
Published: (2020-10-01)

Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I‐III rectal cancer
by: Yuya Nakamura, et al.
Published: (2020-01-01)

Predicting rectal tumor response to neoadjuvant chemoradiotherapy using plasma levels of carcinoembryonic antigen (CEA): Results from a tertiary center in Iran
by: Hadi Ahmadi Amoli, MD, et al.
Published: (2022-12-01)

The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
by: Xie HL, et al.
Published: (2019-08-01)

An Electrochemical Immunosensor for Sensitive Detection of the Tumor Marker Carcinoembryonic Antigen (CEA) Based on Three-Dimensional Porous Nanoplatinum/Graphene
by: Aihua Jing, et al.
Published: (2020-07-01)

Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma
by: Chengcheng Zhang, et al.
Published: (2023-05-01)

High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer
by: Shih-Wei Chen, et al.
Published: (2017-12-01)

CEA as a prognostic index in colorectal cancer
by: Nora Manoukian Forones, et al.

A Novel ssDNA Aptamer Targeting Carcinoembryonic Antigen: Selection and Characterization
by: Nigara Yunussova, et al.
Published: (2022-10-01)

Role of Serum Carcinoembryonic Antigen in Predicting Recurrent Disease following Curative Resection of Rectal Cancer
by: Srikanth Soma, et al.
Published: (2022-04-01)

Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?
by: Dimitrios Filioglou, et al.
Published: (2023-11-01)

Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin
by: Raquel Ibáñez-Pérez, et al.
Published: (2019-11-01)

Multiple myeloma presenting as CEA-producing rectal cancer
by: Giampaolo Talamo
Published: (2010-03-01)

Multivariate Analysis of Prognostic Determinants for Colorectal Cancer Patients with High Preoperative Serum CEA Levels: Prognostic Value of Postoperative Serum CEA Levels
by: Cheng-Jen Ma, et al.
Published: (2006-12-01)

Comparison of IL‐2‐antibody to IL‐2‐Fc with or without stereotactic radiation therapy in CEA immunocompetent mice with CEA positive tumors
by: Lindsay Williams, et al.
Published: (2024-02-01)

High-density controlled environment agriculture (CEA-HD) air distribution optimization using computational fluid dynamics (CFD)
by: Gilbert Larochelle Martin, et al.
Published: (2024-12-01)

Comparison of chemiluminescent microparticle immunoassay (CMIA) with electrochemiluminescence immunoassay (ECLIA) for Carcinoembryonic antigen (CEA)
by: Nafija Serdarevic, et al.
Published: (2018-09-01)

Detection of Carcinoembryonic Antigens Using a Surface Plasmon Resonance Biosensor
by: Shin-Ichiro Nishimura, et al.
Published: (2008-07-01)

Clinicopathological features and survival of colorectal cancer patients younger than 50 years: a retrospective comparative study
by: Robabeh Ghodssi-Ghassemabadi, et al.
Published: (2019-11-01)

A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent
by: David Mant, et al.
Published: (2017-05-01)

Pulmonary cryptococcosis coexisting with adenocarcinoma: a case report and review of the literature
by: Liyang Li, et al.
Published: (2018-11-01)

Effect of UBE2Q on BECN and CEA Protein in Colorectal Cancer Cells
by: Niloofar Boroumand
Published: (2018-12-01)

The Effects of Smoke of Waterpipe and Immobilization Stress on Serum Level of CEA in Female Rats
by: Rahim Ahmadi, et al.
Published: (2013-09-01)